286 related articles for article (PubMed ID: 25955302)
1. Combined expression of ezrin and E-cadherin is associated with lymph node metastasis and poor prognosis in breast cancer.
Yu Z; Sun M; Jin F; Xiao Q; He M; Wu H; Ren J; Zhao L; Zhao H; Yao W; Shan F; Cao Y; Wei M
Oncol Rep; 2015 Jul; 34(1):165-74. PubMed ID: 25955302
[TBL] [Abstract][Full Text] [Related]
2. T-cadherin association with clinicopathological features and prognosis in axillary lymph node-positive breast cancer.
Kong DD; Yang J; Li L; Wang W; Chen YN; Wang SB; Zhou YZ
Breast Cancer Res Treat; 2015 Feb; 150(1):119-26. PubMed ID: 25677746
[TBL] [Abstract][Full Text] [Related]
3. Combined expression of aldehyde dehydrogenase 1A1 and β-catenin is associated with lymph node metastasis and poor survival in breast cancer patients following cyclophosphamide treatment.
Sun M; Zhao H; Xiao Q; Yu Z; Song Z; Yao W; Tang H; Guan S; Jin F; Wei M
Oncol Rep; 2015 Dec; 34(6):3163-73. PubMed ID: 26398662
[TBL] [Abstract][Full Text] [Related]
4. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer.
Yoshida R; Kimura N; Harada Y; Ohuchi N
Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480
[TBL] [Abstract][Full Text] [Related]
5. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
Joo M; Lee HK; Kang YK
Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
[TBL] [Abstract][Full Text] [Related]
6. [Expression of Ezrin and E-cadherin in invasive ductal breast cancer and their correlations to lymphatic metastasis].
Li Q; Wu MF; Song AP; Wei JC; Xu G; Lu YP; Ma D
Ai Zheng; 2006 Mar; 25(3):363-6. PubMed ID: 16536996
[TBL] [Abstract][Full Text] [Related]
7. [Expression of ezrin in human non-small cell lung cancer and its relationship with metastasis and prognosis].
Chen QY; Yan J; Hu HZ; Chen FY; Song J; Jiang ZY; Jiao DM; Wu YQ
Zhonghua Zhong Liu Za Zhi; 2012 Jun; 34(6):436-40. PubMed ID: 22967445
[TBL] [Abstract][Full Text] [Related]
8. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
[TBL] [Abstract][Full Text] [Related]
9. [Relationship between lymph node metastasis and the expressions of E-cadherin, N-cadherin, and matrix metalloproteinase in breast carcinoma].
Wang LH; Liu DY; Chen YJ; Hou L; Wang B; Mao LM; Lu S
Ai Zheng; 2002 Sep; 21(9):965-9. PubMed ID: 12508543
[TBL] [Abstract][Full Text] [Related]
10. [Claudins as prognostic factors of breast cancer].
Szász MA
Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of prognostic parameters of E-cadherin status in breast cancer treatment.
Brzozowska A; Sodolski T; Duma D; Mazurkiewicz T; Mazurkiewicz M
Ann Agric Environ Med; 2012; 19(3):541-6. PubMed ID: 23020053
[TBL] [Abstract][Full Text] [Related]
12. [Relationship of ezrin protein expression to the carcinogenesis and prognosis of infitrating breast ductal carcinoma].
Ma L; Zhang XH; Xing LX; Li YH; Wang XL; Wang YJ
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):279-83. PubMed ID: 18788632
[TBL] [Abstract][Full Text] [Related]
13. Automated quantitative analysis of E-cadherin expression in lymph node metastases is predictive of survival in invasive ductal breast cancer.
Harigopal M; Berger AJ; Camp RL; Rimm DL; Kluger HM
Clin Cancer Res; 2005 Jun; 11(11):4083-9. PubMed ID: 15930343
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Ubiquilin1 expression in invasive breast cancer.
Wang Y; Lu J; Zhao X; Feng Y; Lv S; Mu Y; Wang D; Fu H; Chen Y; Li Y
Cancer Biomark; 2015; 15(5):635-43. PubMed ID: 26406952
[TBL] [Abstract][Full Text] [Related]
15. Prognostic significance of E-cadherin and ezrin immunohistochemical expression in prostate cancer.
Musiał J; Sporny S; Nowicki A
Pol J Pathol; 2007; 58(4):235-43. PubMed ID: 18459457
[TBL] [Abstract][Full Text] [Related]
16. Expression of S100A4, E-cadherin, alpha- and beta-catenin in breast cancer biopsies.
Pedersen KB; Nesland JM; Fodstad Ø; Maelandsmo GM
Br J Cancer; 2002 Nov; 87(11):1281-6. PubMed ID: 12439718
[TBL] [Abstract][Full Text] [Related]
17. Expression of E-cadherin, P-cadherin and N-cadherin in oral squamous cell carcinoma: correlation with the clinicopathologic features and patient outcome.
Pyo SW; Hashimoto M; Kim YS; Kim CH; Lee SH; Johnson KR; Wheelock MJ; Park JU
J Craniomaxillofac Surg; 2007 Jan; 35(1):1-9. PubMed ID: 17296306
[TBL] [Abstract][Full Text] [Related]
18. Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis.
Jeschke U; Mylonas I; Shabani N; Kunert-Keil C; Schindlbeck C; Gerber B; Friese K
Anticancer Res; 2005; 25(3A):1615-22. PubMed ID: 16033070
[TBL] [Abstract][Full Text] [Related]
19. [Expression of Ezrin and E-cadherin in nasopharyngeal carcinoma and its significance].
Wang L; Gao Y; Tu Q; Hong J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2010 Sep; 35(9):969-75. PubMed ID: 20871163
[TBL] [Abstract][Full Text] [Related]
20. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance.
Rakha EA; Abd El Rehim D; Pinder SE; Lewis SA; Ellis IO
Histopathology; 2005 Jun; 46(6):685-93. PubMed ID: 15910600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
